Skip to content
Screener

CONMED CNMD Total Revenue

Total Revenue at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$25.31B+6.6%
Stryker logo
StrykerSYK
$6.59B+9.4%
Boston Scientific logo
Boston ScientificBSX
$5.44B+7.5%
Vericel logo
VericelVCEL
$77.46M+22.5%
OSI Systems logo
OSI SystemsOSIS
$453.25M+2.0%
Zimmer Biomet Holdings logo
Zimmer Biomet HoldingsZBH
$2.18B+4.8%

Segments

By geography

See full
Europe, Middle East & Africa$76.15M+12.3%
Asia Pacific$57.16M+9.7%
Americas (excluding the United States)$34.8M+9.2%

By product

See full
General Surgery$191.17M-5.2%
Orthopedic Surgery$152.32M+8.2%

Other financials

Income statement

See full
Gross profit$197.5M+4.9%
Operating income$36.4M-4.6%
Net income$23.1M+7.7%
EPS (diluted)$0.77+11.6%

Balance sheet

See full
Cash & equivalents$37.3M+10.0%
Total debt$1.0B+14.5%
Total equity$1.0B+3.8%
Total assets$2.3B-1.2%

Cash flow

See full
Operating cash flow$37.1M+27.3%
CapEx$2.9M-48.8%
Free cash flow$34.2M+46.0%

Valuation

See full
Market cap$1.47B-9.4%
Enterprise value$2.45B-1.1%
P/E26×+11.3×
P/S1.1×-0.2×

Profitability

See full
Gross margin55.8%-0.3pp
Operating margin8%-5.0pp
Net margin4.1%-4.2pp
FCF margin9.8%-1.4pp

Returns & leverage

See full
Return on equity5.5%-6.2pp
Debt / equity+0.1×
Current ratio1.5×-0.7×

Where this comes from

Reported directly by CONMED in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The source filing: CONMED’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:13 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000816956-26-000102
Line itemThree Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Net sales$343,488$342,345$660,534$663,600
Cost of sales146,030154,025279,629297,529
Gross profit197,458188,320380,905366,071
Selling and administrative expense145,553136,021287,252284,868
Research and development expense15,50014,13831,83327,084
Operating expenses161,053150,159319,085311,952
Income from operations36,40538,16161,82054,119
Interest expense7,8837,82414,94316,110

Item 1. Financial Statements (unaudited)

FAQ

What is CONMED's total revenue?
CONMED (CNMD) reported total revenue of $343.49M in Q2 2026.
How has CONMED's total revenue changed year-over-year?
CONMED's total revenue increased by 0.3% year-over-year, from $342.35M to $343.49M.
What is the long-term trend for CONMED's total revenue?
Over 4 years (2021 to 2025), CONMED's total revenue has grown at a 8.0% compound annual growth rate (CAGR), from $1.01B to $1.37B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about CONMED's total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude